Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Alaunos Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Peter Harwin, Director (Form 8-K filed 2026-10-13). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Fairmount Funds Management LLC (filed 2026-10-15).
Who is behind it
Alaunos Therapeutics, Inc.: incorporated in Delaware; business address in Fort Lauderdale, Florida; industry Pharmaceutical Preparations (Schedule 13D, 2026-10-15).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D, 2026-10-15 | Fairmount Funds Management LLC | 19.99% |
| Schedule 13D/A, 2026-10-15 | Postma Robert W | 9.99% |
| Schedule 13D/A, 2026-03-05 | Price Adrian | 8.6% |
| Schedule 13D/A, 2026-02-24 | Price Adrian | 8.6% |
| Schedule 13D/A, 2025-12-05 | Price Adrian | 8.6% |
| Schedule 13D/A, 2025-10-31 | Price Adrian | 8.6% |
| Schedule 13D, 2025-10-30 | Price Adrian | 8.6% |
| Schedule 13G/A, 2025-10-16 | Strategic Ep, LLC | 0% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-10-13 | Peter Harwin | Director | appointed |
Money raised
Latest IPO step: Alaunos Therapeutics, Inc. filed to go public (S-1, 2025-10-22).
IPO filings: S-1, 2025-10-22; ticker TRCT on Nasdaq Capital Market.
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-10-13).
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/alaunos-therapeuticsLast updated 2026-10-18
Who owns Alaunos Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/alaunos-therapeutics